Spatiotemporally Controlled Lysosomal Membrane Permeabilization Amplifies STING‐Driven Antitumor Immunity in Prostate Cancer
Advanced Materials · 2026
DOI: 10.1002/adma.74477 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Qishu Jiao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, China. Hauptthemen laut MEDLINE: Lysosomes, Prostatic Neoplasms, Membrane Proteins, Intracellular Membranes. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Project of Development Center for Medical Science & Technology National Health Commission of China, Chongqing Natural Science Foundation Innovation and Development Joint Fund Key Project, Postdoctoral Talent Project in Xinqiao Hospital.
Abstract (Originalsprache)
Prostate cancer (PCa) remains a major clinical challenge due to therapeutic resistance and immunologically cold tumor microenvironment. Lysosomal membrane permeabilization (LMP)–induced lysosome‐dependent cell death offers an alternative route to eliminate resistant tumor cells and initiate immunogenic cell death, yet its efficacy is often limited by insufficient spatiotemporal control and immune activation. Here, we report a spatiotemporally programmable supramolecular nanoplatform (Cu‐P‐MSA) that integrates lysosome‐targeted sonodynamic therapy with tumor‐confined innate immune activation for PCa treatment. Cu‐P‐MSA is a modular self‐assembling peptide incorporating a PSMA‐targeting ligand, morpholine moiety, and cathepsin B–cleavable linker, enabling tumor‐selective uptake and in situ formation of fibrous sonosensitizer depots within lysosomes. Upon ultrasound irradiation, a glutathione‐responsive open‐shell sonosensitizer induces controlled LMP, simultaneously activating ferroptosis and pyroptosis and promoting immunogenic cell death. Meanwhile, tumor‐specific release of a STING agonist MSA‐2 elicits robust type I interferon responses, driving dendritic cell maturation and cytotoxic T‐cell infiltration. This coordinated lysosomal disruption–immune amplification strategy effectively reprograms the tumor immune microenvironment and suppresses both primary and distant tumors, with inhibition rates reaching 84.3% and 77.5%, respectively. Overall, this work establishes a spatiotemporally controlled supramolecular approach that integrates lysosomal disruption with innate immune activation to overcome therapeutic resistance and immunosuppression in PCa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
- Department of Chemistry, China Pharmaceutical University, Nanjing, China.
- Chongqing Engineering Research Center of Tumor Biomarker Translation, Third Military Medical University (Army Medical University), Chongqing, China.
- State Key Laboratory of Trauma and Chemical Poisoning, Third Military Medical University (Army Medical University), Chongqing, China.
ORCID-Profile: Qishu Jiao, Wenying Zhong
Förderung
- Project of Development Center for Medical Science & Technology National Health Commission of China
- Chongqing Natural Science Foundation Innovation and Development Joint Fund Key Project
- Postdoctoral Talent Project in Xinqiao Hospital
- National Natural Science Foundation of China
Zitieren
APA
Jiao, Q., Zhang, J., Wang, C., Liu, Z., Jia, Y., Chen, J., Wang, K., Pei, S., Zhong, W., & Zheng, J. (2026). Spatiotemporally Controlled Lysosomal Membrane Permeabilization Amplifies STING‐Driven Antitumor Immunity in Prostate Cancer. Advanced Materials. https://doi.org/10.1002/adma.74477
Vancouver
Jiao Q, Zhang J, Wang C, Liu Z, Jia Y, Chen J, et al. Spatiotemporally Controlled Lysosomal Membrane Permeabilization Amplifies STING‐Driven Antitumor Immunity in Prostate Cancer. Advanced Materials. 2026. doi:10.1002/adma.74477
BibTeX
@article{Jiao2026,
author = {Jiao, Qishu and Zhang, Jiaqi and Wang, Chunlu and Liu, Zhaohan and Jia, Yongming and Chen, Jia and Wang, Kui and Pei, Shicheng and Zhong, Wenying and Zheng, Ji},
title = {Spatiotemporally Controlled Lysosomal Membrane Permeabilization Amplifies STING‐Driven Antitumor Immunity in Prostate Cancer},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.74477}
}
EUVIMED